Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Method for Improved Intraoperative Blood Loss Estimates (EBL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01634828
Recruitment Status : Completed
First Posted : July 6, 2012
Last Update Posted : May 12, 2016
Sponsor:
Information provided by (Responsible Party):
Annette Macintyre, University of Utah

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The purpose of this study is to develop a mathematical algorithm which the investigators plan to use to more accurately estimate intraoperative blood loss.

Condition or disease
Improved Intraoperative Blood Loss Estimates

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Actual Enrollment : 47 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Method for Improved Intraoperative Blood Loss Estimates
Study Start Date : July 2012
Actual Primary Completion Date : April 2015
Actual Study Completion Date : April 2015

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Bleeding

Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Group/Cohort
Minimal blood loss patients
Moderate to heavy blood loss patients


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Estimate of intraoperative blood loss [ Time Frame: duration of surgery ]

Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 100 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Elective surgical patients
Criteria

Inclusion Criteria:

All elective surgical patients

Exclusion Criteria:

  1. Age < 18
  2. Pregnant women
  3. Prisoners
  4. Lack of informed consent
  5. Attending Physician feels enrollment could interfere with optimal patient care
  6. Patients who did not have a preoperative hemoglobin measured as part of their preoperative work-up
  7. Patients whose preoperative hemoglobin fraction is abnormal.
  8. Patients who will likely require an intraoperative blood transfusion.
  9. Patients for whom the intraoperative use of the Cell Saver is anticipated.
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01634828


Locations
Layout table for location information
United States, Utah
University of Utah
Salt lake City, Utah, United States, 84132
Sponsors and Collaborators
University of Utah
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Annette Macintyre, Principle Investigator, University of Utah
ClinicalTrials.gov Identifier: NCT01634828    
Other Study ID Numbers: FP00002762
56181 ( Registry Identifier: IRB University of Utah )
First Posted: July 6, 2012    Key Record Dates
Last Update Posted: May 12, 2016
Last Verified: May 2016
Additional relevant MeSH terms:
Layout table for MeSH terms
Hemorrhage
Pathologic Processes